Pembrolizumab in Triple-Negative Breast Cancer. Reply. Cortes J, Zhou X, Schmid P. N Engl J Med 2022;387:1436.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cortes J, Zhou X, Schmid P. Pembrolizumab in Triple-Negative Breast Cancer. Reply. N Engl J Med 2022;387:1436.
PMID: 36239658